Following cancer cell death, several cytokines (i.e., IL-1, IL-6, IL-8, IL-12, IL-18) and chemokines such as CCL5 are released that lead to the mobilization and activation of additional immune cells, further contributing to the host’s defense against cancer [54,55]. This evidence concerns the gene CCL5 and cancer.